Efalizumab (Anti-Integrin aL / ITGAL / CD11a)

Efalizumab (Anti-Integrin aL / ITGAL / CD11a) is a humanized IgG1 monoclonal antibody directed against CD11a, the alpha subunit of human leukocyte-function-associated antigen type 1 (LFA-1), with immunosuppressant activity. MW: 145.5 kD.

Catalog Number A2421
CAS# 214745-43-4
Size 1mg*5
Supplier Page http://www.selleckchem.com/products/efalizumab-anti-integrin-al-itgal-cd11a.html